ライフサイエンスコーパス: cytology

1 undetermined significance (hereafter ASC-US cytology).

2 by eyelid margin and conjunctival impression cytology.

3 ne HPV DNA status, HPV 16/18 serostatus, and cytology.

4 enotyping alone and in combination with anal cytology.

5 nts with atypical, negative or indeterminate cytology.

6 ing, "enriched" with 300 women with abnormal cytology.

7 t invasive cervical carcinomas compared with cytology.

8 Rs of primary HPV screening were relative to cytology.

9 r syndrome (DTS) via conjunctival impression cytology.

10 , natural selection, biometry, mutation, and cytology.

11 at 4-month intervals for HPV DNA testing and cytology.

12 as a stand-alone test or in combination with cytology.

13 DNA status, HPV-16 or HPV-18 serostatus, or cytology.

14 Diagnosis was made by biopsy and impression cytology.

15 d be followed without fine-needle aspiration cytology.

16 women underwent HRA following abnormal anal cytology.

17 e HIV-infected women were screened with anal cytology.

18 idence of precursor lesions detected by anal cytology.

19 al disease more accurately than conventional cytology.

20 ctival epithelium was obtained by impression cytology.

21 sociations in vitro, and characterized their cytology.

22 creening algorithm were higher than those of cytology.

23 avoiding unnecessary fine needle aspiration cytologies.

24 pants with negative baseline results of anal cytology, 37% developed abnormal cytology findings (inci

25 a family member due to death) with abnormal cytology (390,310 first abnormal and 1,951,319 normal sm

26 t studies have improved sensitivity over CSF cytology (58%-85%) but have only moderate specificity (8

27 igen (61%; 95% CI, 46% to 74%; P < .001) and cytology (84%; 95% CI, 71% to 92%; P = .02).

28 C): frozen section = 86%, 96%, 0.96 (n = 9); cytology = 91%, 95%, 0.98 (n = 11); intraoperative ultra

29 Cervical cytology abnormality following either HPV vaccination or

30 aphics, clinical characteristics, and sputum cytology after sputum induction were examined.

31 Confocal microscopy and impression cytology agreement in testing the diagnostic hypotheses

32 In comparison, cytology alone in this set provided 43% sensitivity at 1

33 n women aged 30 years or older compared with cytology alone, with no clear advantage over primary HPV

34 ompared to 4/21 cases identified by positive cytology alone.

35 patients that were difficult to diagnose by cytology alone.

36 oVysion probes (45.9%) (P < .001) or routine cytology analysis (18.8%) (P < .001), but similar specif

37 Imprint cytology analysis of SLNs was performed together with th

38 rformance with that of UroVysion and routine cytology analysis.

39 r secondary prevention in triaging low-grade cytology and as a test of cure after treatment.

40 We next review the cytology and cell biology of the multiple-fission cell c

41 different strategies for screening (such as cytology and co-testing).

42 Cytology and cobas and LA HPV testing were conducted for

43 tential to be used in conjunction with urine cytology and cystoscopy to improve clinical diagnosis of

44 edle aspiration include performing cyst wall cytology and DNA analysis.

45 Insights from cytology and double-mutant studies with ameiotic1 and ab

46 Clinic; results were available from routine cytology and FISH with UroVysion probes.

47 evaluate the additional prognostic impact of cytology and growth pattern and to improve risk stratifi

48 Using the Ki-67 index is superior to using cytology and growth pattern as prognostic factors in MCL

49 In men who have sex with men undergoing anal cytology and high-resolution anoscopy, we measured respo

50 type brain tumor patients, preserving tumor cytology and histoarchitecture in all specimens.

51 PV genotypes and anal disease prevalence, by cytology and histopathologic findings, were evaluated am

52 A combination of anal cytology and HPV genotyping provided the highest accurac

53 ss the longitudinal relationship of abnormal cytology and HPV positivity in a 7-year prospective stud

54 articipants and colposcopists were masked to cytology and HPV test results until the colposcopy visit

55 ng interval, screening with a combination of cytology and HPV testing every 5 years.

56 DVICE 4: Clinicians may use a combination of cytology and HPV testing once every 5 years in average-r

57 In this observational study, all cervical cytology and HPV testing reports from January 1, 2007, t

58 Anal cytology and HPV-16 genotyping had the best screening pe

59 Abnormal anal cytology and HPV-16 infection performed best as a screen

60 Anal swab specimens were collected for cytology and human papillomavirus (HPV) testing.

61 lymphadenopathy; the tumor shows high-grade cytology and lacks both BCL2 expression and t(14;18) tra

62 polymerase chain reaction (PCR) and on both cytology and molecular biology for more recent patients.

63 The kappa of concordance between the imprint cytology and OSNA results was 0.52.

64 genitalium and its association with cervical cytology and other correlates, we recruited 350 female s

65 Limitations of biliary cytology and other diagnostic studies have driven the de

66 the cancer burden, the Indian Institute for Cytology and Preventive Oncology, in collaboration with

67 survival, morbidity, endoscopic appearance, cytology and proteomics of brushings, and peripheral blo

68 Using cytology and RAD-seq, we show that C. biroi reproduces v

69 ervical-exfoliation samples for conventional cytology and sexually transmitted infection (STI) testin

70 Conjunctival impression cytology and tear fluid samples were collected at baseli

71 l specimens were screened using liquid-based cytology and tested for >40 HPV types with use of MY09/M

72 comparative test performance of liquid-based cytology and the benefits and harms of human papillomavi

73 images from biological samples (e.g., fixed cytology and tissue sections, live cells or biofluids) t

74 f which were verified pathologically, 111 by cytology and/or during follow-up (at least 24 months).

75 espectively 77.8% for automated, 60-100% for cytology, and 80% for immunostaining based enumeration.

76 The histology, cytology, and distribution of genotype-specific HPV infe

77 e Ki-67 index by using published guidelines, cytology, and growth pattern.

78 th a high-grade colposcopic impression, HSIL cytology, and human papillomavirus (HPV) type 16 positiv

79 ogy for the management of low grade abnormal cytology, and in a test of cure.

80 s and has found its way into histopathology, cytology, and microbiology.

81 e mutation panel was performed for nonbenign cytology, and positive MT results indicated initial TT.

82 of keratitis is based on visual exam, tissue cytology, and standard microbial culturing to determine

83 ficity for CCA, outperforming standard brush cytology, and suggest that the biomarker panel, potentia

84 a high degree of concordance with impression cytology, and to detect limbal alterations associated wi

85 men, the difference in referral rate between cytology- and HPV-screened women was not significant.

86 PV- and/or cytology-positive events, HPV and cytology appeared together approximately 60% of the time

87 CSF cultures and cytology are infrequently positive.

88 MPD) >6 mm, mural nodule (MN) and "positive" cytology as high risk stigmata for malignancy warranting

89 is using a decision tree identified positive cytology as the most important factor (72% relapse rate

90 or control doses, had negative or low-grade cytology at baseline, and had no history of HPV disease.

91 ts in conjunctival cells taken by impression cytology at each visit.

92 ]) HIV-uninfected women with normal cervical cytology at enrollment.

93 79 HIV-uninfected women with normal cervical cytology at their enrollment in a multi-institutional US

94 assigned to HPV-based (experimental arm) or cytology-based (control arm) screening in Sweden (Swedes

95 eening for cervical cancer was compared with cytology-based cervical screening, and precursors of can

96 of the relative efficacy of HPV-based versus cytology-based screening for prevention of invasive canc

97 th diagnosis and death of 11%, compared with cytology-based screening in unvaccinated cohorts.

98 Compared with cytology-based screening, HPV screening is predicted to

99 countries are considering transitioning from cytology-based to HPV-based cervical screening.

100 It was based on cytology before the routine use of polymerase chain reac

101 inated at older age (>/= 18) or had abnormal cytology before vaccination.

102 Established cytology biobanks, typically collected with a cytobrush,

103 eral other HPV types for women with abnormal cytology but not for those with normal cytology, suggest

104 lial neoplasia grade 2+ [CIN2+]) compared to cytology, but no evaluation has been conducted in a popu

105 ong those >/= 18 with no history of abnormal cytology, but there was no evidence of protection among

106 ction follow-up who had HR-HPV screening and cytology by Papanicolaou smear performed yearly between

107 (AUS) after NAC after fine-needle aspiration cytology can identify abnormal nodes and guide patient s

108 mined aggressive disease in 1 false negative cytology case and confirmed a negative cytology diagnosi

109 Of the 9 atypical cytology cases, MP correctly diagnosed 7 as positive and

110 ures with greater accuracy than conventional cytology (CC).

111 Assessment of 4,056 cytology collections by Cervista HPV HR and APTIMA HPV y

112 Histologic analysis and impression cytology confirmed LSCD.

113 Cytology correctly diagnosed aggressive disease in 4 pat

114 ncer at age 21 years once every 3 years with cytology (cytologic tests without human papillomavirus [

115 We analyzed sputum cytology data from 995 subjects with asthma enrolled in

116 ine clinical data included anal and cervical cytology, demographic/behavioral data, and high-resoluti

117 sy with PV associated nephropathy, any urine cytology demonstrating "decoy" cells, and/or significant

118 The worst-ever cytology diagnosis and the 4-year cumulative proportions

119 ative cytology case and confirmed a negative cytology diagnosis in 7 of 7 cases of non-aggressive dis

120 Phenotypes of asthma based on the sputum cytology did not differ between the groups.

121 although statistically significant, abnormal cytology did not increase 5-year risk of CIN3 or worse f

122 wly and prevalently detected events, HPV and cytology disappeared at the same time >70% of the time.

123 4 years, underwent a baseline CXR and sputum cytology examination and received five screening rounds

124 lts of anal cytology, 37% developed abnormal cytology findings (incidence rate, 13.9 cases/100 person

125 The incidence of abnormal anal cytology findings was high and more likely to develop am

126 sent a pragmatic approach to address biliary cytology findings when encountered in PSC.

127 multifaceted approach that involves biliary cytology, FISH, serologic testing and advanced imaging t

128 r with ultrasound and fine-needle aspiration cytology (FNA).

129 Thyroid fine needle aspiration cytology (FNAC) is the standard diagnostic modality for

130 The sensitivity and specificity of urine cytology for detecting UC were 73.9% and 94.7%, respecti

131 ry (FCM) is more sensitive than conventional cytology for detection of occult leptomeningeal lymphoma

132 n addition, data about the accuracy of urine cytology for the detection and the role of the BK virus

133 igher sensitivity but lower specificity than cytology for the identification of high-grade cervical i

134 ervical screening, as an adjunct to cervical cytology for the management of low grade abnormal cytolo

135 m women who underwent AC screening with anal cytology from April 2009 to July 2014 were analyzed.

136 k sonographic characteristics plus follow-up cytology from fine-needle aspiration can identify thyroi

137 We analyzed the nasal cytology from patients before and in season in 2010.

138 oma cell lines that we established exhibited cytology, genomics, mRNA, and protein profiles that were

139 on in young women and in those with abnormal cytology, greater heterogeneity was seen in older women

140 CINtec p16(INK4a) cytology had 85.7% sensitivity, 54.7% specificity, and 4

141 rozen section analysis and touch-preparation cytology have been proposed to address the surgical need

142 Pooled data suggest that frozen section and cytology have the greatest diagnostic accuracy.

143 ritoneal deposits and/or positive peritoneal cytology) have an extremely poor prognosis.

144 ritoneal deposits and/or positive peritoneal cytology) have an extremely poor prognosis.

145 itized C57Bl/6 mice were studied by means of cytology, histology, real-time PCR, and ELISA.

146 In 2 of 7 patients with cytology/histology available at primary diagnosis and at

147 ples from the endometrium were collected for cytology, histopathology, carbohydrate analysis, and exp

148 ked in 14 patients with positive staple line cytology (HR, 0.22; P = .24).

149 Impression cytology (IC) was taken from the bulbar conjunctiva of t

150 ultrasound examinations and reassessment of cytology if significant growth is observed.

151 te-specific antigen, serum creatinine, urine cytology, imaging, cystourethroscopy, post-void residual

152 e Linear Array HPV genotyping assay (LA) and cytology in HIV-infected MSM.

153 mend routine anal cancer screening with anal cytology in persons living with human immunodeficiency v

154 e enforced bacterial culture in the nose and cytology in the nasal smear in asymptomatic (PreAs), sym

155 nant biliary strictures with routine biliary cytology in this population is challenging.

156 en discordant, HPV tended to disappear after cytology in younger and older women.

157 when discordant, HPV tended to appear before cytology in younger and older women.

158 showed mixed results of cotesting (HPV plus cytology) in women aged 30 years or older compared with

159 r of additional tests required (e.g., reflex cytology) in women where underlying CIN2+ is extremely u

160 de precancerous cervical lesions compared to cytology, in a population where high vaccine uptake was

161 a 4% to 9% increased risk for first abnormal cytology, in situ and invasive cervical cancer (all P <

162 th HPV testing, alone or in combination with cytology, in women younger than age 30 years (D recommen

163 Oral exfoliative cytology is a diagnostic method that involves the study

164 Exfoliative cytology is a simple technique that may be used to detec

165 Anal cytology is easy to perform routinely; it may be the bes

166 The sensitivity of CSF cytology is low (2%-32%) but increases when combined wit

167 PV 16/18 to triage women with minor abnormal cytology is poorly sensitive but may be useful as a seco

168 PV 16/18 to triage women with minor abnormal cytology is poorly sensitive but may be useful as a seco

169 Therefore, noninvasive urine cytology is usually used in the clinic as an adjunct to

170 lying cervical atypia missed by conventional cytology, it is limited by a spatial resolution of ~3 mu

171 re 2 (HC2) HPV test (Qiagen) to liquid-based cytology (LBC) for women undergoing routine cervical scr

172 HPV screening versus 2.5-yearly liquid-based cytology (LBC) screening.

173 d LBC screening with HPV triage of low-grade cytology ('LBC screening'), (ii) HPV screening with thos

174 SSA/Ps with cytology markers of dysplasia were associated with a par

175 ing factors; additionally, findings based on cytology may not generalise to human papillomavirus test

176 SurePath and Hologic PreservCyt liquid-based cytology media.

177 cervical specimens collected in liquid-based cytology medium using real-time PCR amplification of the

178 ne, and endocervical samples in liquid-based cytology medium were run on at least two of three platfo

179 p Pap test vial containing PreservCyt liquid cytology medium, and tested in a blinded fashion with co

180 he Clinical Considerations for discussion of cytology method, HPV testing, and screening interval (A

181 Testing for HPV without adjunctive cytology might be sufficiently sensitive for primary scr

182 average-risk women for cervical cancer with cytology more often than once every 3 years.

183 When used in conjunction with first line cytology, MP increased detection of aggressive disease w

184 says, the BD HPV test, and CINtec p16(INK4a) cytology (mtm laboratories) immunocytochemistry.

185 mination (n = 22) and/or positive peritoneal cytology (n = 11) without other organ metastasis were en

186 mination (n = 22) and/or positive peritoneal cytology (n = 11) without other organ metastasis were en

187 women with Hybrid Capture 2 (HC2)-positive, cytology-negative results and who were age >/=30 years f

188 en with human papillomavirus (HPV)-positive, cytology-negative results is critical to the introductio

189 of CIN3+ among all women with HC2-positive, cytology-negative results was 4.6%.

190 ealthy, with no history of abnormal cervical cytology, no previous abnormal cervical biopsy results,

191 We demonstrate that cytology normal HPV+ and HPV- samples contain DNAm patte

192 present evidence that DNAm patterns exist in cytology normal HPV- samples that (i) predispose to neop

193 Cytology-normal/HPV-positive women were invited for repe

194 Cytology of a specimen taken at colposcopy (mild dyskary

195 Cytology of nasal smear by taking with nasal swab and Ha

196 Impression cytology of the lower eyelid margin and tarsal conjuncti

197 These results pave the way for "spectral" cytology of urine using Raman microspectroscopy.

198 gone sputum induction and measures of sputum cytology, often repeatedly, and assessment of responses

199 The relative frequency of indeterminate cytology on FNA could necessitate surgery in a large num

200 Thirty-nine percent had abnormal anal cytology on initial screen and 15% on secondary screen;

201 [CIN3+]) and also found it earlier than did cytology or cotesting.

202 Currently surgeons rely on touch preparation cytology or frozen section analysis to assess tumour mar

203 tatic carcinoma of the pancreas confirmed by cytology or histology.

204 CIN at the resection margins; were tested by cytology or HPV assay between 3 months and 9 months afte

205 sed by histology or immunohistochemistry and cytology or immunocytology.

206 VICE 7: Clinicians should not obtain urinary cytology or other urine-based molecular markers for blad

207 ening for the early detection of UC by urine cytology or periodic sonographic surveys is mandatory, e

208 imaging (P < .001), cancer cells by routine cytology (overall P = .003), as well as absence of prima

209 35% and 50% for carcinoembryonic antigen and cytology ( P < .001 and P = .003, respectively).

210 Greater relative reductions in abnormal cytology (P < 0.001) were observed for HPV-vaccinated wo

211 to 5 years among those with normal cervical cytology (Pap test) results who test negative for oncoge

212 cal cancer in women aged 21 to 65 years with cytology (Papanicolaou smear) every 3 years or, for wome

213 In vivo confocal microscopy and impression cytology (PAS, cytokeratin 12, and cytokeratin 19) stain

214 replication in all kidney biopsies and urine cytologies performed between 1998 and 2014 from kidney t

215 Information yielded with FNA cytology plays an integral role in clinical decision mak

216 e cytology results or 2 consecutive negative cytology plus HPV test results within 10 years, with the

217 Among newly detected HPV- and/or cytology-positive events, HPV and cytology appeared toge

218 seen in older women and in those with normal cytology, possibly reflecting greater variability in exp

219 More sensitive than cytology, primary screening by human papillomavirus test

220 sed cytological specimens, namely, automated cytology processing and glacial acetic acid (GAA) treatm

221 negative result following routine automated cytology processing, despite close proximity to known-po

222 ndent of GAA treatment and routine automated cytology processing.

223 sed in a consecutive fashion by an automated cytology processor without fastidious decontamination pr

224 Performance characteristics of cytology relative to other risk factors were evaluated.

225 The detection rate for an abnormal cervical cytology result during the observation period was lower

226 red for colposcopy because of a cervical Pap cytology result of atypical squamous cells of undetermin

227 The risk for an abnormal cervical cytology result was lower among vaccinated vs unvaccinat

228 ics, clinic type, abnormal baseline cervical cytology result, and baseline Chlamydia screening (as pr

229 For women aged >/=21 years with cytology results indicating atypical squamous cells of u

230 ncer if they have had 3 consecutive negative cytology results or 2 consecutive negative cytology plus

231 Controls were women who had normal cytology results over two subsequent screening rounds at

232 2008 and 2012, and 20677 (4.5%) of the first cytology results per woman were reported as ASC-US.

233 When first line malignant (positive) cytology results were combined with positive second line

234 Cytology results were examined in a total of 30 patients

235 When first line cytology results were uncertain (atypical), questionable

236 6.3% for 14 hrHPV types in women with ASC-US cytology results who were aged >/=21 years and 86.1% in

237 cine effectiveness against abnormal cervical cytology results.

238 was performed and cerebrospinal fluid (CSF) cytology revealed malignant cells compatible with a diag

239 ine the strengths and limitations of biliary cytology, review the application of other techniques to

240 Conjunctival impression cytology samples collected from participants before the

241 2 cytokine profile in bile samples and brush cytology samples from 16 patients with IgG4-related chol

242 erase chain reaction analysis of whole-brush cytology samples from patients with IgG4-related cholang

243 performed a retrospective analysis of 3,518 cytology samples from round 1 ARTISTIC enriched for unde

244 oplasia (CIN2+) in a total of 8,610 cervical cytology samples from the ARTISTIC population-based cerv

245 lticenter, pragmatic study demonstrates that cytology samples obtained from EBUS-TBNA in routine prac

246 BECs isolated from the brush cytology samples revealed decreased levels of claudin-1

247 Thirty-six percent of HC2-positive normal cytology samples were HR HPV negative by both PapilloChe

248 IN2+ detection rates for HPV-screened versus cytology-screened women in Australia's HPV-vaccinated po

249 V-screened group were 41%-44% higher than in cytology-screened women, the difference in referral rate

250 Cytology screening during the detectable preclinical pha

251 We estimate that cervical cytology screening of all women aged 55-79 years in the

252 sought to quantify the efficacy of cervical cytology screening to reduce death from this disease.

253 Urine cytology screening was performed fortnightly from 0 to 3

254 ars of age and underwent subsequent cervical cytology screening.

255 Cytology showed that 45% of PreAs (n=53), 65% of PreSy (

256 ates of human papillomavirus (HPV) triage of cytology showing atypical squamous cells of undetermined

257 MP of DNA from microdissected cytology slides and from discarded supernatant fluid was

258 al profiling (MP) of DNA from microdissected cytology slides and supernatant specimens may play in th

259 Cytology slides were blindly re-reviewed and epithelial

260 s and assessed the potential value of liquid cytology specimens for predicting STIs.

261 to polyacrylamide gel, and 54 biopsies and 2 cytology specimens from 28 control subjects with no adve

262 A genotyping and Q-PCR were performed in 143 cytology specimens from women referred to colposcopy.

263 n-based stratified sample of 59 664 cervical cytology specimens from women residing in New Mexico wer

264 However, it is unclear whether cytology specimens obtained with EBUS-TBNA are suitable

265 case-control study, with 77 biopsies and 30 cytology specimens originating from 59 patients with adv

266 nferior bulbar (IB) and temporal bulbar (TB) cytology specimens stained for MUC5AC revealed a signifi

267 e, and Trichomonas vaginalis in liquid-based cytology specimens were 1.5, 2.1, 0.6, and 4.4%, respect

268 Tear washes and conjunctival impression cytology specimens were collected through standard proce

269 fluorescence in situ hybridization on brush cytology specimens, from two time points with a median i

270 cobas can be used for HPV detection in anal cytology specimens.

271 ormal cytology but not for those with normal cytology, suggesting that type replacement in women vacc

272 Screening for cervical cancer with cytology testing has been very effective in reducing cer

273 sures included: bronchoalveolar lavage fluid cytology to assess airway eosinophilia, pulmonary mechan

274 opic ultrasound with cyst fluid analysis and cytology to confirm the type of cyst and determine the r

275 ave not examined repeated measures of sputum cytology to determine when people with asthma have inter

276 Here we employ genetics, biochemistry and cytology to dissect the role of the linker in FtsZ funct

277 ultrasonography, and fine-needle aspiration cytology to identify 38 patients who received 4 cycles o

278 confocal microscopy, conjunctival impression cytology, tonometry and fundus exam.

279 referred to colposcopy and with dual-stained cytology triage for OHR types ('HPV+DS triage').

280 Impression cytology using immunofluorescent antibodies was performe

281 Cyclic changes in vaginal cytology, uterine histology, serum hormone levels, and w

282 Positive CSF cytology, vitreous biopsy, or brain/leptomeningeal biops

283 ections; the prevalence of abnormal cervical cytology was 38% among women who were HR HPV-positive co

284 Blastoid cytology was associated with inferior OS independently o

285 One specimen that was indeterminate by cytology was correctly diagnosed as non-aggressive by MP

286 Pleural fluid cytology was positive for adenocarcinoma.

287 Cytology was then correlated with histopathology in enuc

288 Impression cytology was used to gather cells from corneal and conju

289 y unknown how infections detected by HPV and cytology wax and wane relative to each other.

290 gin-to-tumor ratio < 1, positive staple line cytology, wedge resection, nodule size > 2.0 cm), SRB di

291 Women with abnormal cytology were managed according to the routine recommend

292 pecific interactions among women with normal cytology, which they consider an indication that type re

293 able to identify patients with indeterminate cytology who can confidently be followed without surgery

294 of all patients (N = 671) with nonmalignant cytology who had thyroidectomy between October 2010 and

295 gnificance/follicular or oncocytic neoplasm) cytology who received initial lobectomy were 2.5 times m

296 for intraepithelial neoplasia or malignancy) cytology who were aged >/=30 years.

297 morphological changes that are identified by cytology with hematoxylin and eosin staining but also pr

298 We evaluated the association of cytology with HRA results, and predictors of HSIL pathol

299 stages, a new approach to small biopsies and cytology with specific terminology and criteria focused

300 To examine 5-year outcomes after ASC-US cytology with vs without HPV testing.